Chief of Research · TriSalus Life Sciences, Inc. · Common Stock
Side
SELL
Value
$1,299
Shares
296
Price
$4.39
Executed
Oct 5, 2026
Disclosed
Oct 7, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Oct 5 executedOct 7, 2026 disclosed
TLSI · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+10 / 15
2 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Cox Bryan F. filed this Form 4 reporting a open-market sale of TLSI on Oct 5, 2026. It became public on Oct 7, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief of Research
Cox Bryan F.cik:0001981787
Issuer
TriSalus Life Sciences, Inc.cik:0001826667
Revision history · 0
No field has changed since this record was first ingested.
